A setback in growing light-responsive crystals led UB chemist Jason Benedict and his team to a novel method for mapping molecular arrangements.
Tactiva Therapeutics, an immuno-oncology company and UB partner, is poised for growth in 2019.
Commission cited trial led by Paresh Dandona in announcing approval for dapagliflozin to treat Type 1 diabetes.
Study is the first to investigate the association between oral contraceptive use and risk of highly fatal ovarian cancer.
Boston College nursing theory and practice expert Dorothy Jones will deliver 22nd annual lecture, part of School of Nursing's Research Day.
Inspired by animals, teams of autonomous robots could alleviate future housing needs in a safe and inexpensive manner, UB engineer Nils Napp says.
Current methods can overestimate cancer growth, hindering clinicians aiblity to schedule screenings and plan treatment.
The new book by UB faculty member Cecil Foster shows the impact of the sleeping car porters on the civil rights movements in the U.S. and Canada.
UB-led research assesses how large-scale patterns of brain activity could vary between cognitive systems and across people.
The material could help reduce utility bills, improve energy efficiency of residential and commercial buildings.
In collaboration with Russian scientists, UB researchers are focused on determining how to detect the biomarker for metastatic prostate cancer.